Quick Answer
Enovix Corp reported R&D Expense of $110.33 million for fiscal year 2025.
Enovix Corp R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $110.33M | -11.4% |
| 2024 | $124.51M | +40.9% |
| 2023 | $88.39M | +52.3% |
| 2022 | $58.05M | +53.4% |
| 2021 | $37.85M | +162.1% |
| 2020 | $14.44M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $28.18M | +16.4% | +0.1% |
| June 30, 2025 | $28.15M | -3.2% | +8.6% |
| March 31, 2025 | $25.93M | -46.9% | +7.1% |
| September 30, 2024 | $24.22M | +79.3% | -16.7% |
| June 30, 2024 | $29.07M | +75.6% | -40.4% |
| March 31, 2024 | $48.79M | +105.4% | +261.2% |
| September 30, 2023 | $13.51M | -3.2% | -18.4% |
| June 30, 2023 | $16.55M | +4.6% | -30.3% |
- Enovix Corp showed a decrease of -11.4% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2025 period, Enovix Corp’s r&d expense has grown by 664.0% (from $14.44 million to $110.33 million).
- The most recent figure is from Enovix Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: